{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T10:44:50Z","timestamp":1783075490388,"version":"3.54.6"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T00:00:00Z","timestamp":1732924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009392","name":"Prince Sattam bin Abdulaziz University","doi-asserted-by":"publisher","award":["PSAU\/2023\/R\/1444"],"award-info":[{"award-number":["PSAU\/2023\/R\/1444"]}],"id":[{"id":"10.13039\/100009392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00284-024-04004-0","type":"journal-article","created":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T15:57:38Z","timestamp":1732982258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bile\u2019s Hidden Weapon: Modulating the Microbiome and Tumor Microenvironment"],"prefix":"10.1007","volume":"82","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Hassan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Fawzi","family":"Al-Hussainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwanjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamata","family":"Chahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waam Mohammed","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood Jasem","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Darvishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahad","family":"Alsaikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,30]]},"reference":[{"issue":"7385","key":"4004_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature10888","volume":"482","author":"A Lujambio","year":"2012","unstructured":"Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482(7385):347\u2013355","journal-title":"Nature"},{"issue":"1","key":"4004_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/medicina56010015","volume":"56","author":"B Arneth","year":"2020","unstructured":"Arneth B (2020) Tumor microenvironment. Medicina 56(1):15","journal-title":"Medicina"},{"issue":"10","key":"4004_CR3","doi-asserted-by":"publisher","first-page":"11149","DOI":"10.1002\/cam4.5698","volume":"12","author":"Q Wang","year":"2023","unstructured":"Wang Q et al (2023) Role of tumor microenvironment in cancer progression and therapeutic strategy. Cancer Med 12(10):11149\u201311165","journal-title":"Cancer Med"},{"issue":"12","key":"4004_CR4","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41579-023-00933-y","volume":"21","author":"SRS Fishbein","year":"2023","unstructured":"Fishbein SRS, Mahmud B, Dantas G (2023) Antibiotic perturbations to the gut microbiome. Nat Rev Microbiol 21(12):772\u2013788","journal-title":"Nat Rev Microbiol"},{"key":"4004_CR5","doi-asserted-by":"crossref","unstructured":"Bayat, M., et al., War or peace: Viruses and metastasis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024. 1879(6): p. 189179.","DOI":"10.1016\/j.bbcan.2024.189179"},{"issue":"1","key":"4004_CR6","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-024-02081-0","volume":"23","author":"M Bayat","year":"2024","unstructured":"Bayat M, Sadri Nahand J (2024) Exosomal miRNAs: the tumor\u2019s trojan horse in selective metastasis. Mol Cancer 23(1):167","journal-title":"Mol Cancer"},{"key":"4004_CR7","doi-asserted-by":"crossref","unstructured":"Mohamadi, S., et al., 2024 The tumor microenvironment's gambit: Exosomal pawns on the board of head and neck cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1879(6): 189189.","DOI":"10.1016\/j.bbcan.2024.189189"},{"issue":"45","key":"4004_CR8","doi-asserted-by":"publisher","first-page":"5904","DOI":"10.1038\/onc.2008.271","volume":"27","author":"TL Whiteside","year":"2008","unstructured":"Whiteside TL (2008) The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45):5904\u20135912","journal-title":"Oncogene"},{"issue":"3","key":"4004_CR9","doi-asserted-by":"publisher","first-page":"e1007581","DOI":"10.1371\/journal.ppat.1007581","volume":"15","author":"MH Foley","year":"2019","unstructured":"Foley MH et al (2019) Bile salt hydrolases: gatekeepers of bile acid metabolism and host-microbiome crosstalk in the gastrointestinal tract. PLoS Pathog 15(3):e1007581","journal-title":"PLoS Pathog"},{"issue":"15","key":"4004_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/cells13151279","volume":"13","author":"AA Kyriazi","year":"2024","unstructured":"Kyriazi AA et al (2024) Intratumoral Microbiome: foe or friend in reshaping the tumor microenvironment landscape? Cells 13(15):1279","journal-title":"Cells"},{"issue":"3","key":"4004_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jcf.2023.09.010","volume":"23","author":"R Bass","year":"2024","unstructured":"Bass R et al (2024) Changes in fecal lipidome after treatment with ivacaftor without changes in microbiome or bile acids. J Cyst Fibros 23(3):481\u2013489","journal-title":"J Cyst Fibros"},{"key":"4004_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.135320","volume":"410","author":"F Ahmad","year":"2023","unstructured":"Ahmad F et al (2023) Diet as a modifiable factor in tumorigenesis: Focus on microbiome-derived bile acid metabolites and short-chain fatty acids. Food Chem 410:135320","journal-title":"Food Chem"},{"key":"4004_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1141215","author":"MP DiPalma","year":"2023","unstructured":"DiPalma MP, Blattman JN (2023) The impact of microbiome dysbiosis on T cell function within the tumor microenvironment (TME). Front Cell Dev Biol. https:\/\/doi.org\/10.3389\/fcell.2023.1141215","journal-title":"Front Cell Dev Biol"},{"key":"4004_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114826","volume":"163","author":"SM Lee","year":"2023","unstructured":"Lee SM et al (2023) Reshaping the gut microbiome and bile acid composition by Gyejibongnyeong-hwan ameliorates western diet-induced dyslipidemia. Biomed Pharmacother 163:114826","journal-title":"Biomed Pharmacother"},{"issue":"5","key":"4004_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s00018-022-04278-2","volume":"79","author":"T Re\u017een","year":"2022","unstructured":"Re\u017een T et al (2022) The role of bile acids in carcinogenesis. Cell Mol Life Sci 79(5):243","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"4004_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/0884533615609899","volume":"30","author":"GA Cresci","year":"2015","unstructured":"Cresci GA, Bawden E (2015) Gut microbiome: what we do and don\u2019t know. Nutr Clin Pract 30(6):734\u2013746","journal-title":"Nutr Clin Pract"},{"issue":"7346","key":"4004_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nature09944","volume":"473","author":"M Arumugam","year":"2011","unstructured":"Arumugam M et al (2011) Enterotypes of the human gut microbiome. Nature 473(7346):174\u2013180","journal-title":"Nature"},{"issue":"9","key":"4004_CR18","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1136\/gutjnl-2018-316723","volume":"67","author":"PD Cani","year":"2018","unstructured":"Cani PD (2018) Human gut microbiome: hopes, threats and promises. Gut 67(9):1716\u20131725","journal-title":"Gut"},{"key":"4004_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.575072","volume":"11","author":"G Longhi","year":"2020","unstructured":"Longhi G et al (2020) Microbiota and cancer: the emerging beneficial role of bifidobacteria in cancer immunotherapy. Front Microbiol 11:575072","journal-title":"Front Microbiol"},{"key":"4004_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.2147\/CMAR.S165228","volume":"10","author":"X Yang","year":"2018","unstructured":"Yang X et al (2018) Role of lactobacillus in cervical cancer. Cancer Manag Res 10:1219\u20131229","journal-title":"Cancer Manag Res"},{"issue":"2","key":"4004_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1053\/j.gastro.2020.09.057","volume":"160","author":"F Shanahan","year":"2021","unstructured":"Shanahan F, Ghosh TS, O\u2019Toole PW (2021) The healthy microbiome\u2014what is the definition of a healthy gut microbiome? Gastroenterology 160(2):483\u2013494","journal-title":"Gastroenterology"},{"issue":"1","key":"4004_CR22","first-page":"23","volume":"33","author":"T Zeng","year":"2024","unstructured":"Zeng T et al (2024) A randomized trial of Bacteroides fragilis 839 on preventing chemotherapy-induced myelosuppression and gastrointestinal adverse effects in breast cancer patients. Asia Pac J Clin Nutr 33(1):23","journal-title":"Asia Pac J Clin Nutr"},{"key":"4004_CR23","doi-asserted-by":"publisher","first-page":"107476","DOI":"10.1016\/j.phrs.2024.107476","volume":"209","author":"J Wu","year":"2024","unstructured":"Wu J et al (2024) Gut microbiota-driven metabolic alterations reveal the distinct pathogenicity of chemotherapy-induced cachexia in gastric cancer. Pharmacol Res 209:107476","journal-title":"Pharmacol Res"},{"key":"4004_CR24","doi-asserted-by":"publisher","first-page":"1230681","DOI":"10.3389\/fimmu.2023.1230681","volume":"14","author":"J Gu","year":"2023","unstructured":"Gu J et al (2023) Deciphering the mechanism of Peptostreptococcus anaerobius-induced chemoresistance in colorectal cancer: The important roles of MDSC recruitment and EMT activation. Front Immunol 14:1230681","journal-title":"Front Immunol"},{"issue":"4","key":"4004_CR25","first-page":"206","volume":"46","author":"M Sidhu","year":"2017","unstructured":"Sidhu M, van der Poorten D (2017) The gut microbiome. Aust Fam Physician 46(4):206\u2013211","journal-title":"Aust Fam Physician"},{"issue":"12","key":"4004_CR26","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.3390\/cells8121471","volume":"8","author":"M Kusaczuk","year":"2019","unstructured":"Kusaczuk M (2019) Tauroursodeoxycholate\u2014bile acid with chaperoning activity: molecular and cellular effects and therapeutic perspectives. Cells 8(12):1471","journal-title":"Cells"},{"issue":"1","key":"4004_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40104-022-00713-3","volume":"13","author":"M Song","year":"2022","unstructured":"Song M et al (2022) Tauroursodeoxycholic acid (TUDCA) improves intestinal barrier function associated with TGR5-MLCK pathway and the alteration of serum metabolites and gut bacteria in weaned piglets. J Animal Sci Biotechnol 13(1):73","journal-title":"J Animal Sci Biotechnol"},{"issue":"9","key":"4004_CR28","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/microorganisms10091792","volume":"10","author":"C An","year":"2022","unstructured":"An C et al (2022) Bile acids: Major regulator of the gut microbiome. Microorganisms 10(9):1792","journal-title":"Microorganisms"},{"issue":"1","key":"4004_CR29","first-page":"398585","volume":"2015","author":"NM Sagar","year":"2015","unstructured":"Sagar NM et al (2015) The interplay of the gut microbiome, bile acids, and volatile organic compounds. Gastroenterol Res Pract 2015(1):398585","journal-title":"Gastroenterol Res Pract"},{"issue":"36","key":"4004_CR30","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","volume":"105","author":"BV Jones","year":"2008","unstructured":"Jones BV et al (2008) Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc Natl Acad Sci 105(36):13580\u201313585","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"4004_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101493","volume":"35","author":"R Li","year":"2021","unstructured":"Li R et al (2021) Gut microbiome and bile acids in obesity-related diseases. Best Pract Res Clin Endocrinol Metab 35(3):101493","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6391","key":"4004_CR32","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma C et al (2018) Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360(6391):eaan5931","journal-title":"Science"},{"issue":"3","key":"4004_CR33","doi-asserted-by":"publisher","first-page":"102354","DOI":"10.1016\/j.bjid.2022.102354","volume":"26","author":"M Abbasi-Kolli","year":"2022","unstructured":"Abbasi-Kolli M et al (2022) The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease. Braz J Infect Dis 26(3):102354","journal-title":"Braz J Infect Dis"},{"key":"4004_CR34","doi-asserted-by":"publisher","first-page":"111036","DOI":"10.1016\/j.biopha.2020.111036","volume":"133","author":"L Wu","year":"2021","unstructured":"Wu L et al (2021) The gut microbiome-bile acid axis in hepatocarcinogenesis. Biomed Pharmacother 133:111036","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"4004_CR35","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1002\/1873-3468.13064","volume":"592","author":"PB Hylemon","year":"2018","unstructured":"Hylemon PB, Harris SC, Ridlon JM (2018) Metabolism of hydrogen gases and bile acids in the gut microbiome. FEBS Lett 592(12):2070\u20132082","journal-title":"FEBS Lett"},{"key":"4004_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-019-0628-3","volume":"7","author":"Z Song","year":"2019","unstructured":"Song Z et al (2019) Taxonomic profiling and populational patterns of bacterial bile salt hydrolase (BSH) genes based on worldwide human gut microbiome. Microbiome 7:1\u201316","journal-title":"Microbiome"},{"issue":"70","key":"4004_CR37","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22803","volume":"8","author":"JP Phelan","year":"2017","unstructured":"Phelan JP et al (2017) Rethinking the bile acid\/gut microbiome axis in cancer. Oncotarget 8(70):115736","journal-title":"Oncotarget"},{"key":"4004_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22111","author":"M Bayat","year":"2023","unstructured":"Bayat M et al (2023) Bile effects on the pseudomonas aeruginosa pathogenesis in cystic fibrosis patients with gastroesophageal reflux. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22111","journal-title":"Heliyon"},{"key":"4004_CR39","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1038\/ncomms7890","volume":"6","author":"A Verch\u00e8re","year":"2015","unstructured":"Verch\u00e8re A et al (2015) In vitro transport activity of the fully assembled MexAB-OprM efflux pump from pseudomonas aeruginosa. Nat Commun 6:6890","journal-title":"Nat Commun"},{"issue":"6","key":"4004_CR40","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/20477724.2021.1916158","volume":"115","author":"A Patil","year":"2021","unstructured":"Patil A et al (2021) Foodborne ESKAPE Biofilms and antimicrobial resistance: lessons learned from clinical isolates. Pathog Glob Health 115(6):339\u2013356","journal-title":"Pathog Glob Health"},{"issue":"1","key":"4004_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijmm.2015.11.004","volume":"306","author":"M Chatterjee","year":"2016","unstructured":"Chatterjee M et al (2016) Antibiotic resistance in pseudomonas aeruginosa and alternative therapeutic options. Int J Med Microbiol 306(1):48\u201358","journal-title":"Int J Med Microbiol"},{"issue":"7","key":"4004_CR42","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3390\/antibiotics10070836","volume":"10","author":"VC Scoffone","year":"2021","unstructured":"Scoffone VC et al (2021) 2021 role of RND efflux pumps in drug resistance of cystic fibrosis pathogens. Antibiotics (Basel) 10(7):836","journal-title":"Antibiotics (Basel)"},{"key":"4004_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2018.00057","author":"B Karim Housseini","year":"2018","unstructured":"Karim Housseini B, Issa GP, Broutin I (2018) Functional mechanism of the efflux pumps transcription regulators from pseudomonas aeruginosa based on 3D structures. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2018.00057","journal-title":"Front Mol Biosci"},{"issue":"5","key":"4004_CR44","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","volume":"48","author":"C Llanes","year":"2004","unstructured":"Llanes C et al (2004) Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously. Antimicrob Agents Chemother 48(5):1797\u20131802","journal-title":"Antimicrob Agents Chemother"},{"key":"4004_CR45","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00865-19","author":"KS Gipson","year":"2020","unstructured":"Gipson KS et al (2020) The Great ESKAPE: exploring the crossroads of bile and antibiotic resistance in bacterial pathogens. Infect Immun. https:\/\/doi.org\/10.1128\/IAI.00865-19","journal-title":"Infect Immun"},{"key":"4004_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02664","author":"PV Pesingi","year":"2019","unstructured":"Pesingi PV et al (2019) MexAB-OprM Efflux pump of pseudomonas aeruginosa offers resistance to carvacrol: a herbal antimicrobial agent. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2019.02664","journal-title":"Front Microbiol"},{"issue":"10","key":"4004_CR47","doi-asserted-by":"publisher","first-page":"e0205036","DOI":"10.1371\/journal.pone.0205036","volume":"13","author":"M Fruci","year":"2018","unstructured":"Fruci M, Poole K (2018) Aminoglycoside-inducible expression of the mexAB-oprM multidrug efflux operon in Pseudomonas aeruginosa: Involvement of the envelope stress-responsive AmgRS two-component system. PLoS ONE 13(10):e0205036","journal-title":"PLoS ONE"},{"key":"4004_CR48","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.mib.2021.09.010","volume":"64","author":"P Laborda","year":"2021","unstructured":"Laborda P et al (2021) Pseudomonas aeruginosa: an antibiotic resilient pathogen with environmental origin. Curr Opin Microbiol 64:125\u2013132","journal-title":"Curr Opin Microbiol"},{"issue":"6","key":"4004_CR49","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00203-016-1215-7","volume":"198","author":"YP Pan","year":"2016","unstructured":"Pan YP et al (2016) Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Arch Microbiol 198(6):565\u2013571","journal-title":"Arch Microbiol"},{"issue":"4","key":"4004_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1556\/030.66.2019.036","volume":"66","author":"Y Khalili","year":"2019","unstructured":"Khalili Y et al (2019) Characterization of carbapenem-resistant but cephalosporin-susceptible Pseudomonas aeruginosa. Acta Microbiol Immunol Hung 66(4):529\u2013540","journal-title":"Acta Microbiol Immunol Hung"},{"key":"4004_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IDR.S233987","volume":"13","author":"Y Xu","year":"2020","unstructured":"Xu Y et al (2020) High expression of metallo-\u03b2-lactamase contributed to the resistance to carbapenem in clinical isolates of Pseudomonas aeruginosa from baotou. China Infect Drug Resist 13:35\u201343","journal-title":"China Infect Drug Resist"},{"key":"4004_CR52","doi-asserted-by":"publisher","first-page":"29768","DOI":"10.1038\/srep29768","volume":"6","author":"FJ Reen","year":"2016","unstructured":"Reen FJ et al (2016) Bile signalling promotes chronic respiratory infections and antibiotic tolerance. Sci Rep 6:29768","journal-title":"Sci Rep"},{"issue":"7","key":"4004_CR53","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3390\/antibiotics10070766","volume":"10","author":"DF Woods","year":"2021","unstructured":"Woods DF et al (2021) 2021 systems biology and bile acid signalling in microbiome-host interactions in the cystic fibrosis lung. Antibiotics (Basel) 10(7):766","journal-title":"Antibiotics (Basel)"},{"issue":"2","key":"4004_CR54","first-page":"102","volume":"18","author":"MR Arabestani","year":"2015","unstructured":"Arabestani MR et al (2015) Expression of efflux pump MexAB-OprM and OprD of Pseudomonas aeruginosa strains isolated from clinical samples using qRT-PCR. Arch Iran Med 18(2):102\u2013108","journal-title":"Arch Iran Med"},{"issue":"1","key":"4004_CR55","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.1038\/ncomms7890","volume":"6","author":"A Verch\u00e8re","year":"2015","unstructured":"Verch\u00e8re A et al (2015) In vitro transport activity of the fully assembled MexAB-OprM efflux pump from Pseudomonas aeruginosa. Nat Commun 6(1):6890","journal-title":"Nat Commun"},{"issue":"6","key":"4004_CR56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/20477724.2021.1916158","volume":"115","author":"A Patil","year":"2021","unstructured":"Patil A et al (2021) Foodborne ESKAPE biofilms and antimicrobial resistance: lessons learned from clinical isolates. Pathogens and Global Health 115(6):339\u2013356","journal-title":"Pathogens and Global Health"},{"key":"4004_CR57","doi-asserted-by":"crossref","unstructured":"Housseini B Issa, K., G. Phan, and I. Broutin, 2018 Functional mechanism of the efflux pumps transcription regulators from Pseudomonas aeruginosa based on 3D structures. Frontiers in molecular biosciences, 2018. 5: p. 57.","DOI":"10.3389\/fmolb.2018.00057"},{"key":"4004_CR58","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00203-016-1215-7","volume":"198","author":"Y-P Pan","year":"2016","unstructured":"Pan Y-P et al (2016) Overexpression of MexAB-OprM efflux pump in carbapenem-resistant Pseudomonas aeruginosa. Arch Microbiol 198:565\u2013571","journal-title":"Arch Microbiol"},{"issue":"2","key":"4004_CR59","first-page":"255","volume":"3","author":"K Poole","year":"2001","unstructured":"Poole K (2001) Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 3(2):255\u2013264","journal-title":"J Mol Microbiol Biotechnol"},{"key":"4004_CR60","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3389\/fcimb.2017.00143","volume":"7","author":"M L\u00f3pez","year":"2017","unstructured":"L\u00f3pez M et al (2017) Response to bile salts in clinical strains of Acinetobacter baumannii lacking the AdeABC efflux pump: virulence associated with quorum sensing. Front Cell Infect Microbiol 7:143","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"4004_CR61","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1038\/s41598-021-82603-8","volume":"11","author":"S-W Suh","year":"2021","unstructured":"Suh S-W et al (2021) Antibiotic selection based on microbiology and resistance profiles of bile from gallbladder of patients with acute cholecystitis. Sci Rep 11(1):2969","journal-title":"Sci Rep"},{"issue":"8","key":"4004_CR62","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1099\/mic.0.000317","volume":"162","author":"D Ulluwishewa","year":"2016","unstructured":"Ulluwishewa D et al (2016) Dissecting the regulation of bile-induced biofilm formation in staphylococcus aureus. Microbiology 162(8):1398\u20131406","journal-title":"Microbiology"},{"issue":"1","key":"4004_CR63","doi-asserted-by":"publisher","first-page":"25543","DOI":"10.1038\/srep25543","volume":"6","author":"J-Y Lee","year":"2016","unstructured":"Lee J-Y et al (2016) Evolved resistance to colistin and its loss due to genetic reversion in Pseudomonas aeruginosa. Sci Rep 6(1):25543","journal-title":"Sci Rep"},{"key":"4004_CR64","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s10096-016-2669-x","volume":"35","author":"E Tajeddin","year":"2016","unstructured":"Tajeddin E et al (2016) Association of diverse bacterial communities in human bile samples with biliary tract disorders: a survey using culture and polymerase chain reaction-denaturing gradient gel electrophoresis methods. Eur J Clin Microbiol Infect Dis 35:1331\u20131339","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4004_CR65","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00527-17","author":"B Wulkersdorfer","year":"2017","unstructured":"Wulkersdorfer B et al (2017) Human bile reduces antimicrobial activity of selected antibiotics against enterococcus faecalis and escherichia coli in vitro. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00527-17","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"4004_CR66","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","volume":"5","author":"L Ding","year":"2015","unstructured":"Ding L et al (2015) Bile acid nuclear receptor FXR and digestive system diseases. Acta Pharmaceutica Sinica B 5(2):135\u2013144","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"6","key":"4004_CR67","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1042\/EBC20210038","volume":"65","author":"Q Tang","year":"2021","unstructured":"Tang Q, Evans RM (2021) Colon cancer checks in when bile acids check out: the bile acid\u2013nuclear receptor axis in colon cancer. Essays Biochem 65(6):1015\u20131024","journal-title":"Essays Biochem"},{"issue":"2","key":"4004_CR68","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.apsb.2023.11.011","volume":"14","author":"W Lun","year":"2024","unstructured":"Lun W et al (2024) Mechanism of action of the bile acid receptor TGR5 in obesity. Acta Pharmaceutica Sinica B 14(2):468\u2013491","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"4004_CR69","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00223.2019","author":"JY Chiang","year":"2020","unstructured":"Chiang JY, Ferrell JM (2020) Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol-Gastrointest Liver Physiol. https:\/\/doi.org\/10.1152\/ajpgi.00223.2019","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"4004_CR70","doi-asserted-by":"publisher","first-page":"875593","DOI":"10.3389\/fimmu.2022.875593","volume":"13","author":"Y Ma","year":"2022","unstructured":"Ma Y et al (2022) Reduced peroxisome proliferator-activated receptor-\u03b1 and bile acid nuclear receptor NR1H4\/FXR may affect the hepatic immune microenvironment of biliary atresia. Front Immunol 13:875593","journal-title":"Front Immunol"},{"issue":"11","key":"4004_CR71","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.3390\/microorganisms11112730","volume":"11","author":"Y Kiriyama","year":"2023","unstructured":"Kiriyama Y, Nochi H (2023) The role of gut microbiota-derived lithocholic acid, deoxycholic acid and their derivatives on the function and differentiation of immune cells. Microorganisms 11(11):2730","journal-title":"Microorganisms"},{"key":"4004_CR72","doi-asserted-by":"publisher","first-page":"813745","DOI":"10.3389\/fonc.2022.813745","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y et al (2022) Secondary bile acids and tumorigenesis in colorectal cancer. Front Oncol 12:813745","journal-title":"Front Oncol"},{"key":"4004_CR73","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1007\/s00432-021-03729-w","volume":"147","author":"N Dalal","year":"2021","unstructured":"Dalal N et al (2021) Gut microbiota-derived metabolites in CRC progression and causation. J Cancer Res Clin Oncol 147:3141\u20133155","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"4004_CR74","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1007\/s12072-022-10299-7","volume":"16","author":"R Shen","year":"2022","unstructured":"Shen R et al (2022) Abnormal bile acid-microbiota crosstalk promotes the development of hepatocellular carcinoma. Hep Intl 16(2):396\u2013411","journal-title":"Hep Intl"},{"issue":"2","key":"4004_CR75","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/med.21991","volume":"44","author":"K Wang","year":"2024","unstructured":"Wang K et al (2024) FXR agonists for MASH therapy: lessons and perspectives from obeticholic acid. Med Res Rev 44(2):568\u2013586","journal-title":"Med Res Rev"},{"issue":"6","key":"4004_CR76","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41417-020-00239-8","volume":"28","author":"J Yu","year":"2021","unstructured":"Yu J et al (2021) Synergistic tumor inhibition of colon cancer cells by nitazoxanide and obeticholic acid, a farnesoid X receptor ligand. Cancer Gene Ther 28(6):590\u2013601","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"4004_CR77","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1016\/j.apsb.2020.09.004","volume":"10","author":"G Ji","year":"2020","unstructured":"Ji G et al (2020) Precise delivery of obeticholic acid via nanoapproach for triggering natural killer T cell-mediated liver cancer immunotherapy. Acta Pharmaceutica Sinica B 10(11):2171\u20132182","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"24","key":"4004_CR78","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/cancers13246213","volume":"13","author":"C Gee","year":"2021","unstructured":"Gee C et al (2021) Bile acid malabsorption as a consequence of cancer treatment: prevalence and management in the national leading centre. Cancers 13(24):6213","journal-title":"Cancers"},{"issue":"11","key":"4004_CR79","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1016\/j.clinthera.2009.11.027","volume":"31","author":"L Wedlake","year":"2009","unstructured":"Wedlake L et al (2009) Effectiveness and tolerability of colesevelam hydrochloride for bile-acid malabsorption in patients with cancer: a retrospective chart review and patient questionnaire. Clin Ther 31(11):2549\u20132558","journal-title":"Clin Ther"},{"issue":"1","key":"4004_CR80","doi-asserted-by":"publisher","first-page":"2410475","DOI":"10.1080\/19490976.2024.2410475","volume":"16","author":"BR Loman","year":"2024","unstructured":"Loman BR et al (2024) Paclitaxel chemotherapy disrupts microbiota-enterohepatic bile acid metabolism in mice. Gut Microbes 16(1):2410475","journal-title":"Gut Microbes"},{"issue":"4","key":"4004_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijo.2022.5407","volume":"61","author":"W Luo","year":"2022","unstructured":"Luo W et al (2022) Hepatocellular carcinoma: novel understandings and therapeutic strategies based on bile acids. Int J Oncol 61(4):1\u201312","journal-title":"Int J Oncol"},{"issue":"6","key":"4004_CR82","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1634\/theoncologist.6-6-517","volume":"6","author":"YA Elsayed","year":"2001","unstructured":"Elsayed YA, Sausville EA (2001) Selected novel anticancer treatments targeting cell signaling proteins. Oncologist 6(6):517\u2013537","journal-title":"Oncologist"},{"key":"4004_CR83","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/bs.apha.2015.04.003","volume":"74","author":"T Li","year":"2015","unstructured":"Li T, Apte U (2015) Bile acid metabolism and signaling in cholestasis, inflammation, and cancer. Adv Pharmacol 74:263\u2013302","journal-title":"Adv Pharmacol"},{"issue":"6","key":"4004_CR84","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/jcsm.12798","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng L et al (2021) Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome. J Cachexia Sarcopenia Muscle 12(6):1553\u20131569","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4004_CR85","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci S et al (2018) Bile acids activated receptors regulate innate immunity. Front Immunol 9:1853","journal-title":"Front Immunol"},{"issue":"1","key":"4004_CR86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12950-024-00417-7","volume":"21","author":"H Bannazadeh Baghi","year":"2024","unstructured":"Bannazadeh Baghi H et al (2024) Regulatory role of microRNAs in virus-mediated inflammation. J Inflamm 21(1):43","journal-title":"J Inflamm"},{"issue":"9","key":"4004_CR87","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","volume":"16","author":"Y Li","year":"2017","unstructured":"Li Y et al (2017) Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun Rev 16(9):885\u2013896","journal-title":"Autoimmun Rev"},{"issue":"6","key":"4004_CR88","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1073\/pnas.1524890113","volume":"113","author":"PP Ho","year":"2016","unstructured":"Ho PP, Steinman L (2016) Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis. Proc Natl Acad Sci 113(6):1600\u20131605","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"4004_CR89","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41385-019-0162-4","volume":"12","author":"ML Chen","year":"2019","unstructured":"Chen ML, Takeda K, Sundrud MS (2019) Emerging roles of bile acids in mucosal immunity and inflammation. Mucosal Immunol 12(4):851\u2013861","journal-title":"Mucosal Immunol"},{"issue":"7785","key":"4004_CR90","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S et al (2019) Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576(7785):143\u2013148","journal-title":"Nature"},{"key":"4004_CR91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","volume":"56","author":"M Li","year":"2017","unstructured":"Li M, Cai S-Y, Boyer JL (2017) Mechanisms of bile acid mediated inflammation in the liver. Mol Aspects Med 56:45\u201353","journal-title":"Mol Aspects Med"},{"issue":"4 Suppl 98","key":"4004_CR92","first-page":"25","volume":"34","author":"C Zhu","year":"2016","unstructured":"Zhu C et al (2016) Bile acids in regulation of inflammation and immunity: friend or foe. Clin Exp Rheumatol 34(4 Suppl 98):25\u201331","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4004_CR93","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo C et al (2016) Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45(4):802\u2013816","journal-title":"Immunity"},{"issue":"5","key":"4004_CR94","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/imcb.12332","volume":"98","author":"A Liston","year":"2020","unstructured":"Liston A, Whyte CE (2020) Bile acids mediate signaling between microbiome and the immune system. Immunol Cell Biol 98(5):349\u2013350","journal-title":"Immunol Cell Biol"},{"issue":"1","key":"4004_CR95","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12935-023-03022-5","volume":"23","author":"M Eslami","year":"2023","unstructured":"Eslami M et al (2023) MiRNA-related metastasis in oral cancer: moving and shaking. Cancer Cell Int 23(1):182","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4004_CR96","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1186\/s12885-021-08658-y","volume":"21","author":"JS Nahand","year":"2021","unstructured":"Nahand JS et al (2021) Possible role of HPV\/EBV coinfection in anoikis resistance and development in prostate cancer. BMC Cancer 21(1):926","journal-title":"BMC Cancer"},{"issue":"1","key":"4004_CR97","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10565-024-09907-z","volume":"40","author":"M Bayat","year":"2024","unstructured":"Bayat M, Nahand JS (2024) Let\u2019s make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment. Cell Biol Toxicol 40(1):61","journal-title":"Cell Biol Toxicol"},{"issue":"1","key":"4004_CR98","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1186\/s12885-020-07428-6","volume":"20","author":"M Rezaei","year":"2020","unstructured":"Rezaei M et al (2020) The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue. BMC Cancer 20(1):916","journal-title":"BMC Cancer"},{"issue":"5","key":"4004_CR99","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s13238-020-00813-8","volume":"12","author":"A Wong-Rolle","year":"2020","unstructured":"Wong-Rolle A et al (2020) Unexpected guests in the tumor microenvironment: microbiome in cancer. Protein Cell 12(5):426\u2013435","journal-title":"Protein Cell"},{"issue":"5","key":"4004_CR100","doi-asserted-by":"publisher","first-page":"761","DOI":"10.7150\/jca.17648","volume":"8","author":"M Wang","year":"2017","unstructured":"Wang M et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8(5):761\u2013773","journal-title":"J Cancer"},{"key":"4004_CR101","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbac018","author":"W Yang","year":"2022","unstructured":"Yang W, Yu T, Cong Y (2022) CD4(+) T cell metabolism, gut microbiota, and autoimmune diseases: implication in precision medicine of autoimmune diseases. Precis Clin Med. https:\/\/doi.org\/10.1093\/pcmedi\/pbac018","journal-title":"Precis Clin Med"},{"issue":"5","key":"4004_CR102","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4161\/gmic.1.5.12925","volume":"1","author":"R Mercado-Lubo","year":"2010","unstructured":"Mercado-Lubo R, McCormick BA (2010) The interaction of gut microbes with host ABC transporters. Gut Microbes 1(5):301\u2013306","journal-title":"Gut Microbes"},{"key":"4004_CR103","doi-asserted-by":"publisher","first-page":"1033145","DOI":"10.3389\/fonc.2022.1033145","volume":"12","author":"JK Xia","year":"2022","unstructured":"Xia JK et al (2022) Deregulated bile acids may drive hepatocellular carcinoma metastasis by inducing an immunosuppressive microenvironment. Front Oncol 12:1033145","journal-title":"Front Oncol"},{"issue":"7785","key":"4004_CR104","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang S et al (2019) Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature 576(7785):143\u2013148","journal-title":"Nature"},{"issue":"9","key":"4004_CR105","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","volume":"29","author":"W Li","year":"2021","unstructured":"Li W et al (2021) A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. Cell Host Microbe 29(9):1366-1377.e9","journal-title":"Cell Host Microbe"},{"key":"4004_CR106","unstructured":"!!! INVALID CITATION !!! {Li, 2021 #573;Li, 2021 #573;Li, 2021 #573;Ding, 2022 #575;Deng, 2024 #1376}."},{"issue":"9","key":"4004_CR107","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200332R","volume":"36","author":"C Ding","year":"2022","unstructured":"Ding C et al (2022) Bile acid restrained T cell activation explains cholestasis aggravated hepatitis B virus infection. FASEB J 36(9):e22468","journal-title":"FASEB J"},{"issue":"1","key":"4004_CR108","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41598-017-18305-x","volume":"8","author":"M Wammers","year":"2018","unstructured":"Wammers M et al (2018) Reprogramming of pro-inflammatory human macrophages to an anti-inflammatory phenotype by bile acids. Sci Rep 8(1):255","journal-title":"Sci Rep"},{"issue":"8","key":"4004_CR109","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2174\/156800906779010236","volume":"6","author":"N Deuk Kim","year":"2006","unstructured":"Deuk Kim N et al (2006) Modulation of the cell cycle and induction of apoptosis in human cancer cells by synthetic bile acids. Curr Cancer Drug Targets 6(8):681\u2013689","journal-title":"Curr Cancer Drug Targets"},{"issue":"4","key":"4004_CR110","doi-asserted-by":"publisher","first-page":"636","DOI":"10.2174\/138920111795163986","volume":"12","author":"R Wang","year":"2011","unstructured":"Wang R, Sheps JA, Ling V (2011) ABC transporters, bile acids, and inflammatory stress in liver cancer. Current Pharma Biotechnol 12(4):636\u2013646","journal-title":"Current Pharma Biotechnol"},{"key":"4004_CR111","doi-asserted-by":"publisher","first-page":"778258","DOI":"10.3389\/fonc.2021.778258","volume":"11","author":"J Fu","year":"2021","unstructured":"Fu J et al (2021) Research progress of bile acids in cancer. Front Oncol 11:778258","journal-title":"Front Oncol"},{"issue":"1","key":"4004_CR112","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.canlet.2009.08.030","volume":"290","author":"MK Baek","year":"2010","unstructured":"Baek MK et al (2010) Lithocholic acid upregulates uPAR and cell invasiveness via MAPK and AP-1 signaling in colon cancer cells. Cancer Lett 290(1):123\u2013128","journal-title":"Cancer Lett"},{"issue":"8","key":"4004_CR113","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/00042737-200108000-00012","volume":"13","author":"V Milovic","year":"2001","unstructured":"Milovic V et al (2001) Deoxycholic acid stimulates migration in colon cancer cells. Eur J Gastroenterol Hepatol 13(8):945\u2013949","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"21","key":"4004_CR114","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.3390\/ijms21218042","volume":"21","author":"F Quilty","year":"2020","unstructured":"Quilty F et al (2020) Impact of deoxycholic acid on oesophageal adenocarcinoma invasion: effect on matrix metalloproteinases. Int J Mol Sci 21(21):8042","journal-title":"Int J Mol Sci"},{"key":"4004_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-018-0569-0","volume":"18","author":"Y-C Wu","year":"2018","unstructured":"Wu Y-C et al (2018) The role of bile acids in cellular invasiveness of gastric cancer. Cancer Cell Int 18:1\u20138","journal-title":"Cancer Cell Int"},{"issue":"3","key":"4004_CR116","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/hep.30852","volume":"71","author":"X Jia","year":"2020","unstructured":"Jia X et al (2020) Characterization of gut microbiota, bile acid metabolism, and cytokines in intrahepatic cholangiocarcinoma. Hepatology 71(3):893\u2013906","journal-title":"Hepatology"},{"issue":"3","key":"4004_CR117","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.3892\/ol.2016.4842","volume":"12","author":"GY Park","year":"2016","unstructured":"Park GY et al (2016) Tauroursodeoxycholic acid reduces the invasion of MDA-MB-231 cells by modulating matrix metalloproteinases 7 and 13. Oncol Lett 12(3):2227\u20132231","journal-title":"Oncol Lett"},{"issue":"5","key":"4004_CR118","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00284-022-02807-7","volume":"79","author":"N Eslami","year":"2022","unstructured":"Eslami N et al (2022) SARS-CoV-2: receptor and Co-receptor tropism probability. Curr Microbiol 79(5):133","journal-title":"Curr Microbiol"},{"issue":"2","key":"4004_CR119","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","volume":"15","author":"W Jia","year":"2018","unstructured":"Jia W, Xie G, Jia W (2018) Bile acid\u2013microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat Rev Gastroenterol Hepatol 15(2):111\u2013128","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"4004_CR120","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.chom.2019.03.008","volume":"25","author":"PT McKenney","year":"2019","unstructured":"McKenney PT et al (2019) Intestinal bile acids induce a morphotype switch in vancomycin-resistant enterococcus that facilitates intestinal colonization. Cell Host Microbe 25(5):695-705.e5","journal-title":"Cell Host Microbe"},{"key":"4004_CR121","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01067-16","author":"KP Nickerson","year":"2017","unstructured":"Nickerson KP et al (2017) Analysis of shigella flexneri resistance, biofilm formation, and transcriptional profile in response to bile salts. Infect Immun. https:\/\/doi.org\/10.1128\/IAI.01067-16","journal-title":"Infect Immun"},{"issue":"17","key":"4004_CR122","doi-asserted-by":"publisher","first-page":"4509","DOI":"10.1128\/JB.00200-11","volume":"193","author":"JV Kus","year":"2011","unstructured":"Kus JV et al (2011) Bile salts induce resistance to polymyxin in enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 193(17):4509\u20134515","journal-title":"J Bacteriol"},{"issue":"8","key":"4004_CR123","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1099\/mic.0.000317","volume":"162","author":"D Ulluwishewa","year":"2016","unstructured":"Ulluwishewa D et al (2016) Dissecting the regulation of bile-induced biofilm formation in Staphylococcus aureus. Microbiology (Reading) 162(8):1398\u20131406","journal-title":"Microbiology (Reading)"},{"issue":"1","key":"4004_CR124","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13099-014-0040-2","volume":"6","author":"B Zheng","year":"2014","unstructured":"Zheng B et al (2014) Genome sequencing and genomic characterization of a tigecycline-resistant Klebsiella pneumoniae strain isolated from the bile samples of a cholangiocarcinoma patient. Gut Pathog 6(1):40","journal-title":"Gut Pathog"},{"key":"4004_CR125","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2017.00143","author":"M L\u00f3pez","year":"2017","unstructured":"L\u00f3pez M et al (2017) Response to bile salts in clinical strains of acinetobacter baumannii lacking the AdeABC efflux pump: virulence associated with quorum sensing. Front Cell Infect Microbiol. https:\/\/doi.org\/10.3389\/fcimb.2017.00143","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-04004-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-024-04004-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-024-04004-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T02:03:09Z","timestamp":1736560989000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-024-04004-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,30]]},"references-count":125,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4004"],"URL":"https:\/\/doi.org\/10.1007\/s00284-024-04004-0","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,30]]},"assertion":[{"value":"31 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"25"}}